Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Goodin

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2006
Pharmacokinetics of cetuximab after administration of escalating single dosing and weekly fixed dosing in patients with solid tumorsAntoinette R Tan, Dirk F Moore, Manuel Hidalgo, et al.
The Prostate|August 6, 2010
Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignanciesMark Stein, Hongxia Lin, Chandrika Jeyamohan, et al.
International Journal of Medical Sciences|May 30, 2017
The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate CancerLin Yu, Xiaofeng Wu, Min Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2017
Brefeldin A enhances docetaxel-induced growth inhibition and apoptosis in prostate cancer cells in monolayer and 3D culturesHuarong Huang, Ting Liu, Junxi Guo, et al.
International Journal of Medical Sciences|July 28, 2020
Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D culturesDongli Li, Yuran Ma, Wenfeng Liu, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancerSusan Goodin, Kamakshi V Rao, Michael Kane, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 1, 2015
ASHP guidelines on preventing medication errors with chemotherapy and biotherapyBarry Goldspiel, James M Hoffman, Niesha L Griffith, et al.
Bioscience, Biotechnology, and Biochemistry|July 10, 2020
Combination of diethyldithiocarbamate with 12-O-tetradecanoyl phorbol-13-acetate inhibits the growth of human myeloid leukemia HL-60 cells <i>in vitro</i> and in xenograft modelYuran Ma, Shaohua Chen, Min Chen, et al.
Bioorganic Chemistry|June 30, 2020
(3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cellsPanpan Wu, Xiao Wang, Yuran Ma, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2007
Clinical and biological activity of soy protein powder supplementation in healthy male volunteersSusan Goodin, Francisco Shen, Weichung J Shih, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2006
Pharmacokinetics of cetuximab after administration of escalating single dosing and weekly fixed dosing in patients with solid tumorsAntoinette R Tan, Dirk F Moore, Manuel Hidalgo, et al.
The Prostate|August 6, 2010
Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignanciesMark Stein, Hongxia Lin, Chandrika Jeyamohan, et al.
International Journal of Medical Sciences|May 30, 2017
The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate CancerLin Yu, Xiaofeng Wu, Min Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2017
Brefeldin A enhances docetaxel-induced growth inhibition and apoptosis in prostate cancer cells in monolayer and 3D culturesHuarong Huang, Ting Liu, Junxi Guo, et al.
International Journal of Medical Sciences|July 28, 2020
Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D culturesDongli Li, Yuran Ma, Wenfeng Liu, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancerSusan Goodin, Kamakshi V Rao, Michael Kane, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 1, 2015
ASHP guidelines on preventing medication errors with chemotherapy and biotherapyBarry Goldspiel, James M Hoffman, Niesha L Griffith, et al.
Bioscience, Biotechnology, and Biochemistry|July 10, 2020
Combination of diethyldithiocarbamate with 12-O-tetradecanoyl phorbol-13-acetate inhibits the growth of human myeloid leukemia HL-60 cells <i>in vitro</i> and in xenograft modelYuran Ma, Shaohua Chen, Min Chen, et al.
Bioorganic Chemistry|June 30, 2020
(3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cellsPanpan Wu, Xiao Wang, Yuran Ma, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2007
Clinical and biological activity of soy protein powder supplementation in healthy male volunteersSusan Goodin, Francisco Shen, Weichung J Shih, et al.
Pageof 8